An investigation on cervical cancer and human papillomavirus vaccine knowledge, and analysis of influencing factors for choosing domestic or imported 2vHPV vaccine among females in Shenzhen, China

• Ngā kaituhi matua: Linxiang Chen (Author), Fangfang Lu (Author), Ziqi Wang (Author), Hanqing Chen (Author), Mianling Chen (Author), Chunmiao Peng (Author), Kangming Chen (Author), Cuili Chen (Author), Huawei Xiong (Author), Xu Xie (Author)
• Hōputu: Pukapuka
• I whakaputaina: Taylor & Francis Group, 2023-08-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

In 2020, the domestic (Chinese native) 2v human papillomavirus (HPV) vaccine was approved for use in females. At present, there are obvious differences in demand for different HPV vaccines. We aimed to investigate knowledge level of cervical cancer and HPV vaccine and its influencing factors among t...